1 / 7

EpiCast Report: Fibromyalgia - Epidemiology Market Forecast

Market Research Report on"EpiCast Report: Fibromyalgia - Epidemiology Market Forecast to 2023 " is a professional and deep research report in this field

Download Presentation

EpiCast Report: Fibromyalgia - Epidemiology Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Market Research Store Fibromyalgia Epidemiology Market Size, Share, Global Trends, Analysis, Research Report and Forecast, 2015- 2025 www.marketresearchstore.com sales@marketresearchstore.com

  2. EpiCastReport: Fibromyalgia - Epidemiology Market Forecast to 2023 Table of content Fibromyalgia, also known as fibromyalgia syndrome and fibrositis, is a common form of nonarticular rheumatism that is associated with chronic, widespread musculoskeletal pain, generalized tender joints, fatigue, and a long list of wide-ranging symptoms, such as fatigue, sleep disturbances, irritable bowel syndrome (IBS), headaches, and depression. Fibromyalgia is a complex illness to diagnose and treat, as it is idiopathic, and its symptoms may be part of or overlap with other diseases. For this analysis, epidemiologists defined fibromyalgia using the International Classification of Diseases, Ninth Revision (ICD-9) code for fibromyalgia (729.1) and the International Classification of Diseases, Tenth Revision (ICD-10) code for fibromyalgia (M79.7). GlobalData epidemiologists used country-specific studies that provided the total prevalence of fibromyalgia using the 2010 American College of Rheumatology (ACR) classification criteria for this epidemiological forecast.

  3. Table of content Report Description In 2013, there were 23,663,533 total prevalent cases of fibromyalgia in the 7MM. GlobalData epidemiologists forecast that the total prevalent cases in the 7MM will increase to 24,881,838 by 2023, at an Annual Growth Rate (AGR) of 0.51%. All markets, except for Germany and Japan, will see a small increase in the number of cases at varying AGRs. Since GlobalData epidemiologists held the prevalence constant throughout the forecast period, the differences observed in the total prevalent cases of fibromyalgia in the 7MM are driven by changes in the underlying population dynamics of each market. In the 7MM, fibromyalgia epidemiological studies have shown that women have a higher total prevalence of fibromyalgia compared with men. When the 1990 ACR criteria were used to define fibromyalgia, a majority of patients with fibromyalgia were women due to the greater number of female body tender points.

  4. Table of content Report Description However, the 2010 ACR criteria are entirely symptom-based, do not require tender point counts, and provide a more accurate sex distribution of total prevalent cases of fibromyalgia (Wolfe et al., 2011). Additional studies are needed to clarify the etiology of the association between sex and fibromyalgia. Visit Complete Report @ http://www.marketresearchstore.com/report/epicast-report-fibromyalgia-epidemiology-forecast-to-2023-18227 Get Sample Copy of Report: http://www.marketresearchstore.com/report/epicast-report-fibromyalgia-epidemiology-forecast-to-2023-18227#requestSample

  5. Table of content Report Description • Scope • The Fibromyalgia EpiCast Report provides an overview of the risk factors, global, and historical trends of fibromyalgia in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of fibromyalgia total prevalent cases segmented by age (in five-year increments for all ages), sex, and pain severity (mild, moderate, and severe) in these seven markets. • The fibromyalgia epidemiology report is written and developed by Masters- and PhD-level epidemiologists. • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. • Browse Full Report with TOC : • http://www.marketresearchstore.com/report/epicast-report-fibromyalgia-epidemiology-forecast-to-2023-18227#reportTableOfContent

  6. Table of content Report Description • Reasons to buy • Develop business strategies by understanding the trends shaping and driving the global fibromyalgia market. • Quantify patient populations in the global fibromyalgia market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for fibromyalgia therapeutics in each of the markets covered. • Identify the percentage of fibromyalgia total prevalent cases by severity. • Get Sample Copy of Report: • http://www.marketresearchstore.com/report/epicast-report-fibromyalgia-epidemiology-forecast-to-2023-18227#requestSample

  7. About Us Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Contact Us Stay With Us: TELEPHONE: +1-386-310-3803 E-MAIL: sales@marketresearchstore.com Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442 United States

More Related